LONG-TERM OUTCOMES WITH INITIAL TRIPLE ORAL THERAPY IN PULMONARY ARTERIAL HYPERTENSION (PAH): INSIGHTS FROM TRITON

被引：0
|
作者：
Howard, L. [1 ]
Sitbon, O. [2 ]
Galie, N. [3 ]
Doelberg, M. [4 ]
Gibbs, J. S. R. [5 ]
Hoeper, M. M. [6 ,7 ]
Stefani, M. [4 ]
Mathai, S. C. [8 ]
McLaughlin, Vv [9 ]
Perchenet, L. [4 ]
Simonneau, G. [2 ]
Chin, K. M. [10 ]
机构：
[1] Hammersmith Hosp, London, England
[2] Univ Paris Sud, Hop Bicetre, Le Kremlin Bicetre, France
[3] Univ Bologna, Bologna, Italy
[4] Actel Pharmaceut Ltd, Allschwil, Switzerland
[5] Imperial Coll, Natl Heart & Lung Inst, London, England
[6] Hannover Med Sch, Hannover, Germany
[7] German Ctr Lung Res, Hannover, Germany
[8] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[9] Univ Michigan, Ann Arbor, MI 48109 USA
[10] UT Southwestern Med Ctr, Dallas, TX USA
来源：
THORAX | 2021年 / 76卷
关键词：
D O I：
10.1136/thorax-2020-BTSabstracts.99
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
S94
引用
收藏
页码：A57 / A57
页数：1
相关论文
共 50 条
  • [21] Combination Therapy For Pulmonary Arterial Hypertension With Oral Treprostinil: Long-Term Follow Up
    Ruggiero, R. M.
    Bartolome, S.
    Chin, K. M.
    Torres, F.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [22] Long-Term Outcomes With Ambrisentan Monotherapy in Pulmonary Arterial Hypertension
    Blalock, Shannon E.
    Matulevicius, Susan
    Mitchell, Laura C.
    Reimold, Sharon
    Warner, John
    Peshock, Ronald
    Torres, Fernando
    Chin, Kelly M.
    JOURNAL OF CARDIAC FAILURE, 2010, 16 (02) : 121 - 127
  • [23] Early selexipag initiation and long-term outcomes: insights from randomised controlled trials in pulmonary arterial hypertension
    Coghlan, J. Gerry
    Gaine, Sean
    Channick, Richard
    Chin, Kelly M.
    du Roure, Camille
    Gibbs, J. Simon R.
    Hoeper, Marius M.
    Lang, Irene M.
    Mathai, Stephen C.
    McLaughlin, Vallerie V.
    Mitchell, Lada
    Simonneau, Gerald
    Sitbon, Olivier
    Tapson, Victor F.
    Galie, Nazzareno
    ERJ OPEN RESEARCH, 2023, 9 (01)
  • [24] Long-term outcomes and predictors of mortality in systemic lupus erythematosus (SLE) associated pulmonary arterial hypertension (PAH)
    Li, M.
    Wang, Q.
    Zhao, J.
    Zeng, X.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2015, 33 (03) : S48 - S48
  • [25] Long-Term Ambrisentan Therapy for the Treatment of Pulmonary Arterial Hypertension
    Oudiz, Ronald J.
    Galie, Nazzareno
    Olschewski, Horst
    Torres, Fernando
    Frost, Adaani
    Ghofrani, Hossein A.
    Badesch, David B.
    McGoon, Michael D.
    McLaughlin, Vallerie V.
    Roecker, Ellen B.
    Harrison, Brooke C.
    Despain, Darrin
    Dufton, Christopher
    Rubin, Lewis J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 54 (21) : 1971 - 1981
  • [26] Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension
    Ghofrani, HA
    Rose, F
    Schermuly, RT
    Olschewski, H
    Wiedemann, R
    Kreckel, A
    Weissmann, N
    Ghofrani, S
    Enke, B
    Seeger, W
    Grimminger, F
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (01) : 158 - 164
  • [27] Survival in Childhood Pulmonary Arterial Hypertension Insights From the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management
    Barst, Robyn J.
    McGoon, Michael D.
    Elliott, C. Gregory
    Foreman, Aimee J.
    Miller, Dave P.
    Ivy, D. Dunbar
    CIRCULATION, 2012, 125 (01) : 113 - 122
  • [28] Impact of initial therapeutic strategy on long-term outcomes in pulmonary arterial hypertension: An analysis of the PHSANZ registry
    Kearney, K.
    Lavender, M.
    Cordina, R.
    Collins, N.
    Corrigan, C.
    Dwyer, N.
    Feenstra, J.
    Keating, D.
    McWilliams, T.
    Williams, T.
    Whitford, H.
    Whyte, K.
    Weintraub, R.
    Wrobel, J.
    Keogh, A.
    Kotlyar, E.
    Lau, E.
    RESPIROLOGY, 2022, 27 : 50 - 50
  • [29] Impact of Initial Therapeutic Strategy on Long-Term Outcomes in Pulmonary Arterial Hypertension: An Analysis of the PHSANZ Registry
    Kearney, K.
    Lavender, M.
    Cordina, R.
    Collins, N.
    Corrigan, C.
    Dwyer, N.
    Feenstra, J.
    Keating, D.
    McWilliams, T.
    Williams, T.
    Whitford, H.
    Wrobel, J.
    Keogh, A.
    Kotlyar, E.
    Lau., E.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (04): : S27 - S28
  • [30] Effect of selexipag on long-term outcomes in patients with pulmonary arterial hypertension (PAH) receiving one, two or no PAH therapies at baseline: results from the GRIPHON study
    Lang, I.
    Gaine, S.
    Galie, N.
    Ghofrani, H. A.
    Le Brun, F. O.
    McLaughlin, V.
    Rubin, L. J.
    Simonneau, G.
    Sitbon, O.
    Hoeper, M.
    EUROPEAN HEART JOURNAL, 2015, 36 : 381 - 382
12345